Same Day Discharge Following Pelvic Reconstructive Surgery

TriHealth

Status: Completed

Conditions: Same Day Discharge; Pelvic Organ Prolapse; Total Vaginal Hysterectomy

Treatments: Procedure: Pelvic Reconstructive Surgery

Study type: Observational

Funder types: Other

Identifiers

NCT04804826

21-010

Details and patient eligibility

About

This is a prospective cross-sectional study in which patients undergoing major pelvic reconstructive surgery with total vaginal hysterectomy will be recruited and enrolled. At approximately 2 weeks and 12 weeks postoperatively, enrolled patients will be asked to complete a survey detailing their experience with SDD, surgical recovery, and advice for prospective patients.

Enrollment: 54 patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Total vaginal hysterectomy with or without bilateral salpingectomy/oophorectomy
• Apical repair with uterosacral ligament suspension or sacrospinous ligament fixation
• They may also have any of the following concurrent procedures: Anterior repair, Posterior repair, Enterocele repair, Suburethral sling for incontinence
• Surgery by one of the fellowship trained urogynecologists at TriHealth
• English speaking

Exclusion criteria

• Enrollment in the "Diazepam Research Study" (Protocol ID:19-130)
• Concomitant procedure with another surgeon
• Chronic pain conditions that require daily use of narcotic pain medications (including but not limited to: chronic back or pelvic pain, interstitial cystitis, fibromyalgia)
• Concomitant anal sphincteroplasty, mesh removal or use of mesh for prolapse (excluding sling procedures)